Trident Texofab Limited (BOM:540726)
India · Delayed Price · Currency is INR 269.00
+4.15 (1.57%)
At close: Jan 16, 2026
Trident Texofab Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,286 | 1,221 | 994.83 | 963.56 | 842.93 | 499.27 | Upgrade |
Other Revenue | - | - | 0 | - | - | - | Upgrade |
| 1,286 | 1,221 | 994.84 | 963.56 | 842.93 | 499.27 | Upgrade | |
Revenue Growth (YoY) | 22.09% | 22.69% | 3.25% | 14.31% | 68.83% | -45.11% | Upgrade |
Cost of Revenue | 1,096 | 1,058 | 838.32 | 803.93 | 722.59 | 421.1 | Upgrade |
Gross Profit | 189.61 | 162.33 | 156.52 | 159.64 | 120.34 | 78.16 | Upgrade |
Selling, General & Admin | 29.47 | 28.75 | 27.08 | 28.02 | 24.59 | 20.54 | Upgrade |
Other Operating Expenses | 72.38 | 78.86 | 67.89 | 49.52 | 35.77 | 25.28 | Upgrade |
Operating Expenses | 118.24 | 124.09 | 111.45 | 93.98 | 75.02 | 56.05 | Upgrade |
Operating Income | 71.37 | 38.24 | 45.07 | 65.66 | 45.31 | 22.11 | Upgrade |
Interest Expense | -40.33 | -45.26 | -40.22 | -55.63 | -39.97 | -31.4 | Upgrade |
Interest & Investment Income | 1.85 | 1.85 | 1.37 | 1.15 | 0.61 | 15.53 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | 0.16 | 0.94 | Upgrade |
Other Non Operating Income (Expenses) | -26.9 | 1.08 | 1.35 | 1.57 | 3.69 | 1.39 | Upgrade |
EBT Excluding Unusual Items | 6 | -4.09 | 7.56 | 12.75 | 9.79 | 8.57 | Upgrade |
Gain (Loss) on Sale of Investments | 29.84 | 29.84 | 1.02 | 15.81 | 2.52 | - | Upgrade |
Other Unusual Items | - | - | 3.11 | -1.3 | 0.43 | 0.47 | Upgrade |
Pretax Income | 35.84 | 25.76 | 11.69 | 27.26 | 12.73 | 9.04 | Upgrade |
Income Tax Expense | 6.3 | 0.66 | 0.89 | 5.08 | 2.91 | 5.51 | Upgrade |
Net Income | 29.54 | 25.1 | 10.8 | 22.18 | 9.83 | 3.53 | Upgrade |
Net Income to Common | 29.54 | 25.1 | 10.8 | 22.18 | 9.83 | 3.53 | Upgrade |
Net Income Growth | 37.08% | 132.46% | -51.32% | 125.74% | 178.31% | -60.78% | Upgrade |
Shares Outstanding (Basic) | 13 | 10 | 10 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 14 | 12 | 10 | 10 | 10 | 10 | Upgrade |
Shares Change (YoY) | 42.36% | 16.16% | -0.00% | 0.00% | 0.79% | 4.18% | Upgrade |
EPS (Basic) | 2.35 | 2.44 | 1.07 | 2.20 | 0.98 | 0.35 | Upgrade |
EPS (Diluted) | 2.02 | 2.09 | 1.07 | 2.20 | 0.98 | 0.35 | Upgrade |
EPS Growth | -5.74% | 95.33% | -51.36% | 125.44% | 178.82% | -62.72% | Upgrade |
Free Cash Flow | -138.96 | -137.22 | 26.56 | 56.36 | -27.64 | -79.56 | Upgrade |
Free Cash Flow Per Share | -9.70 | -11.73 | 2.64 | 5.60 | -2.75 | -7.96 | Upgrade |
Gross Margin | 14.74% | 13.30% | 15.73% | 16.57% | 14.28% | 15.65% | Upgrade |
Operating Margin | 5.55% | 3.13% | 4.53% | 6.81% | 5.38% | 4.43% | Upgrade |
Profit Margin | 2.30% | 2.06% | 1.08% | 2.30% | 1.17% | 0.71% | Upgrade |
Free Cash Flow Margin | -10.80% | -11.24% | 2.67% | 5.85% | -3.28% | -15.93% | Upgrade |
EBITDA | 86.44 | 53.4 | 60.24 | 80.81 | 58.21 | 30.47 | Upgrade |
EBITDA Margin | 6.72% | 4.38% | 6.05% | 8.39% | 6.91% | 6.10% | Upgrade |
D&A For EBITDA | 15.08 | 15.16 | 15.17 | 15.15 | 12.9 | 8.36 | Upgrade |
EBIT | 71.37 | 38.24 | 45.07 | 65.66 | 45.31 | 22.11 | Upgrade |
EBIT Margin | 5.55% | 3.13% | 4.53% | 6.81% | 5.38% | 4.43% | Upgrade |
Effective Tax Rate | 17.57% | 2.55% | 7.61% | 18.62% | 22.83% | 60.95% | Upgrade |
Revenue as Reported | 1,291 | 1,254 | 998.72 | 982.6 | 850.34 | 517.79 | Upgrade |
Advertising Expenses | - | 0.1 | 0.13 | 0.33 | 0.15 | 0.07 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.